<ѻýҕl>Zytiga May Up Mortality Risk in Prostate Cancer Patients With CVDѻýҕl> Increased hospitalizations seen among all abiraterone-treated patients Feb 27, 2019
<ѻýҕl>One-Time FIT Adequately Detects CRC but Not Advanced Adenomasѻýҕl> Accuracy depends on varying test thresholds for positive result Feb 25, 2019
<ѻýҕl>Significant Decline in Precancerous Cervical Lesions in U.S.ѻýҕl> Proportion of lesions with HPV16/18 fall across age, ethnic groups Feb 21, 2019
<ѻýҕl>No Survival Bump Yet with Tivozanib for RCCѻýҕl> Selected studies on kidney cancer from the Genitourinary Cancers Symposium Feb 18, 2019
<ѻýҕl>'Encouraging' Early Data with Keytruda in High-Risk Bladder Caѻýҕl> Will responses in non-muscle-invasive, BCG-unresponsive disease prove durable? Feb 17, 2019
<ѻýҕl>Bladder Ca Treatment Enters 'Post-Checkpoint' Eraѻýҕl> Early trials show responses with antibody-drug conjugates Feb 16, 2019
<ѻýҕl>Doubling Down on Antiandrogens Improves PFS in Metastatic Prostate Caѻýҕl> But lack of OS data for enzalutamide-ADT may hold it back Feb 15, 2019 video
<ѻýҕl>Immunotherapy Lurches Forward in Prostate Cancerѻýҕl> Combination trials in mCRPC yield responses in immunologically "cold" tumor Feb 15, 2019
<ѻýҕl>Surveillance of Low-Risk Prostate Cancer Tripledѻýҕl> Radical prostatectomy gained some ground for high-risk disease Feb 12, 2019 video
<ѻýҕl>Radiological Agent Shows Promise in Heavily Treated mCRPCѻýҕl> PSA decline of 50% or greater in two-thirds of patients Feb 12, 2019 video
<ѻýҕl>Better Survival for African-Americans With mCRPCѻýҕl> Significant improvement vs whites with androgen-directed agents Feb 11, 2019 video
<ѻýҕl>Andexanet Holds Strong as Antidote to Apixaban, Rivaroxabanѻýҕl> Reversal agent for factor Xa inhibitors soon to be subject to a randomized trial Feb 08, 2019
<ѻýҕl>Fewer Colectomy Procedures Performed Among Ulcerative Colitis Patientsѻýҕl> Surveillance efforts may lead to more treatment options for this patient group Feb 08, 2019
<ѻýҕl>Colonoscopy Misses More Adenomas Than Thoughtѻýҕl> Forget 'one and done' -- adenomas per positive colonoscopy better measure of quality, researchers say Feb 08, 2019
<ѻýҕl>Rats, My PSA Went Up. Do I Need Another Bleeping Biopsy?ѻýҕl> "Active surveillance" doesn't have to mean invasive testing for every biomarker blip Jan 29, 2019
<ѻýҕl>Rapid Heart Rate Tied to Higher Mortality in Cancer Patientsѻýҕl> Unexplained tachycardia linked with threefold increase in risk of death Jan 28, 2019
<ѻýҕl>Genetic Profiling Disappoints for CUP Survivalѻýҕl> But testing in cancer of unknown primary site did help with prognosis Jan 24, 2019
<ѻýҕl>High Response Rate in HER2+ Esophagogastric Cancerѻýҕl> Summary findings from the Gastrointestinal Cancers Symposium Jan 23, 2019
<ѻýҕl>Death Risk Rises With No Colonoscopy After Stage I CRCѻýҕl> Three-fold increase, but is colonoscopy the driver? Jan 22, 2019
<ѻýҕl>Mixed Results with Immune Tx in Advanced, Refractory Colon Caѻýҕl> Overall survival gains were modest to none in different stages of CRC Jan 20, 2019
<ѻýҕl>Metastatic Gastric Ca Treatments Show Mixed Resultsѻýҕl> FTD/TPI effective, but mFOLFOX plus biologic didn't improve survival Jan 20, 2019
<ѻýҕl>'Incredibly Impressive' Activity in Biliary Ca with Combo Txѻýҕl> Responses in about 40% of patients with BRAF/MEK inhibitor pairing Jan 20, 2019
<ѻýҕl>Will Biomarkers Eventually Replace Physicians?ѻýҕl> Milton Packer imagines the end of nonprocedural medicine as we know it Jan 16, 2019
<ѻýҕl>Surgery/HIPEC Safer Than Other High-Risk Cancer Proceduresѻýҕl> Lower infection, 30-day mortality rates than with Whipple, esophagectomy Jan 15, 2019
<ѻýҕl>Active Smokers Far More Likely to Fail on Chemo for Bladder Caѻýҕl> Higher rates of disease recurrence seen as well Jan 10, 2019
<ѻýҕl>V600K-Mutant Melanoma May Merit First-Line Immunotherapyѻýҕl> Higher mutational load is less responsive to targeted therapy with BRAF/MEK inhibition Jan 10, 2019
<ѻýҕl>Less Invasive Surgery Wins in Esophageal Cancerѻýҕl> Large reduction in major complications at 1 month out Jan 09, 2019
<ѻýҕl>Does Johnson's Baby Powder Cause Cancer?ѻýҕl> Milton Packer says the $4.69-billion verdict is about anger, not medicine Jan 09, 2019
<ѻýҕl>Trump Proposes Overhaul of Part B Drugsѻýҕl> Plan hinges on benchmarking U.S. prices to those abroad Jan 04, 2019
<ѻýҕl>MSI Status in Prostate Ca Could ID Immunotherapy Respondersѻýҕl> But not all MSI-high patients saw benefit with checkpoint inhibitors Dec 27, 2018
<ѻýҕl>Cancer Treatment and Arthritis: A Growing Complaintѻýҕl> Will checkpoint inhibitor-related arthritis outstrip RA in frequency? Dec 27, 2018
<ѻýҕl>Increased Risk of Chemo-Associated AML for Nearly All Solid Cancersѻýҕl> Extended beyond 5 years for most types with greater risk seen in young patients Dec 20, 2018
<ѻýҕl>Kidney Stones Tied to Renal Carcinomaѻýҕl> But more research is needed to unravel mechanisms behind the relationships, study authors say Dec 20, 2018
<ѻýҕl>Sorafenib 'New Standard of Care' for Patients With Desmoid Tumorsѻýҕl> Toxicity led to treatment discontinuation in 20% of patients Dec 19, 2018
<ѻýҕl>Higher Risk of Shingles Seen in Patients With Certain Cancersѻýҕl> Vaccine development may help with prevention of herpes zoster in this population Dec 14, 2018
<ѻýҕl>Immunotherapy Combo Flops in Metastatic NSCLCѻýҕl> Durvalumab plus tremelimumab failed to improve survival versus chemotherapy Dec 13, 2018
<ѻýҕl>Patients Say Quality of Life Suffered With Mastectomy for Early Breast Cancerѻýҕl> Breast-conservation options were associated with better sexual, psychosocial outcomes Dec 07, 2018
<ѻýҕl>Visual Guide to AVERT's VTE Prevention in Cancerѻýҕl> Apixaban effective against important chemotherapy side effect Dec 07, 2018
<ѻýҕl>In Lupus, Risks for Cancers Riseѻýҕl> Overall risks increased for both women and men Dec 07, 2018
<ѻýҕl>ASH Poster Rounds: Adding BTK Inhibitor Safe in First-Line MCLѻýҕl> Plus: Lenalidomide upfront in PTCL; skipping RT in primary mediastinal B-cell lymphoma Dec 07, 2018